169 related articles for article (PubMed ID: 21060278)
1. Re: Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.
Ranchod TM; Leverenz VR; Chintala SK; Cheng M; Trese MT; Giblin FJ
Retina; 2010; 30(10):1752-4; author reply 1754. PubMed ID: 21060278
[No Abstract] [Full Text] [Related]
2. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.
Diago T; McCannel CA; Bakri SJ; Pulido JS; Edwards AO; Pach JM
Retina; 2009 May; 29(5):601-5. PubMed ID: 19357558
[TBL] [Abstract][Full Text] [Related]
3. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.
Tabatabaii A; Ahmadraji A; Khodabande A; Mansouri M
Middle East Afr J Ophthalmol; 2013; 20(1):87-8. PubMed ID: 23580860
[TBL] [Abstract][Full Text] [Related]
4. Endophthalmitis after anti-VEGF injections.
Klein KS; Walsh MK; Hassan TS; Halperin LS; Castellarin AA; Roth D; Driscoll S; Prenner JL
Ophthalmology; 2009 Jun; 116(6):1225.e1. PubMed ID: 19486799
[No Abstract] [Full Text] [Related]
5. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.
Pilli S; Kotsolis A; Spaide RF; Slakter J; Freund KB; Sorenson J; Klancnik J; Cooney M
Am J Ophthalmol; 2008 May; 145(5):879-82. PubMed ID: 18329624
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
7. Intraocular inflammation after intravitreal ranibizumab injections.
Fauser S; Schroeder S; Caramoy A; Kirchhof B; Lappas A
Acta Ophthalmol; 2011 Feb; 89(1):e98-9. PubMed ID: 20384590
[No Abstract] [Full Text] [Related]
8. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
[TBL] [Abstract][Full Text] [Related]
9. Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection.
Aggio FB; Farah ME; de Melo GB; d'Azevedo PA; Pignatari AC; Höfling-Lima AL
Eye (Lond); 2007 Mar; 21(3):408-9. PubMed ID: 17277758
[TBL] [Abstract][Full Text] [Related]
10. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
[TBL] [Abstract][Full Text] [Related]
11. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
[TBL] [Abstract][Full Text] [Related]
12. Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.
Haddock LJ; Ramsey DJ; Young LH
Semin Ophthalmol; 2014; 29(5-6):257-62. PubMed ID: 25325851
[TBL] [Abstract][Full Text] [Related]
13. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.
Casparis H; Wolfensberger TJ; Becker M; Eich G; Graf N; Ambresin A; Mantel I; Michels S
Retina; 2014 Jan; 34(1):12-7. PubMed ID: 23945639
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
[TBL] [Abstract][Full Text] [Related]
15. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
[TBL] [Abstract][Full Text] [Related]
16. Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
Chen E; Lin MY; Cox J; Brown DM
Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Bhatt SS; Stepien KE; Joshi K
Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
[TBL] [Abstract][Full Text] [Related]
19. Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial.
Khan P; Khan L; Mondal P
Indian J Ophthalmol; 2016 Sep; 64(9):694-696. PubMed ID: 27853027
[TBL] [Abstract][Full Text] [Related]
20. A case of sterile endophthalmitis after repeated intravitreal bevacizumab injection.
Yenerel NM; Dinc UA; Gorgun E
J Ocul Pharmacol Ther; 2008 Jun; 24(3):362-3. PubMed ID: 18476807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]